Johnson & Johnson (JNJ) — Analyst outlook / Analyst consensus target is. Based on 40 analyst ratings, the consensus is bullish — 20 Buy, 17 Hold, 3 Sell.
The consensus price target is $228.73 (low: $190.00, high: $265.00), representing a downside of 4.7% from the current price $240.10.
Analysts estimate Earnings Per Share (EPS) of $9.95 and revenue of $88.78B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $5.84 vs est $9.95 (missed -41.3%). 2025: actual $11.03 vs est $10.80 (beat +2.1%). Analyst accuracy: 64%.
JNJ Stock — 12-Month Price Forecast
$228.73
▼ -4.74% Downside
Average Price Target
Based on 40 Wall Street analysts offering 12-month price targets for Johnson & Johnson, the average price target is $228.73, with a high forecast of $265.00, and a low forecast of $190.00.
The average price target represents a -4.74% change from the last price of $240.10.
Highest Price Target
$265.00
Average Price Target
$228.73
Lowest Price Target
$190.00
JNJ Analyst Ratings
Buy
Based on 40 analysts giving stock ratings to Johnson & Johnson in the past 3 months
EPS Estimates — JNJ
64%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $5.84
vs Est $9.95
▼ 70.4% off
2025
Actual $11.03
vs Est $10.80
▲ 2.1% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — JNJ
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $88.821B
vs Est $88.777B
▲ 0.0% off
2025
Actual $94.193B
vs Est $93.759B
▲ 0.5% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
